Beta-lactam dosing during continuous renal replacement therapy: a survey of practices in french intensive care units
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2369
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Beta-lactam dosing during continuous renal replacement therapy: a survey of practices in french intensive care units ; volume:23 ; number:1 ; day:29 ; month:1 ; year:2022 ; pages:1-10 ; date:12.2022
BMC nephrology ; 23, Heft 1 (29.1.2022), 1-10, 12.2022
- Creator
-
Matusik, Elodie
Lemtiri, Justine
Wabont, Guillaume
Lambiotte, Fabien
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12882-022-02678-x
- URN
-
urn:nbn:de:101:1-2022050807494707177203
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Matusik, Elodie
- Lemtiri, Justine
- Wabont, Guillaume
- Lambiotte, Fabien
- SpringerLink (Online service)
Other Objects (12)
Beta-lactam antibiotic dosing during continuous renal replacement therapy: how can we optimize therapy?
Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy
Optimization of beta-lactam dosing through targeted therapeutic drug monitoring
β-lactam antibiotic concentrations during continuous renal replacement therapy
Renal replacement therapy does have impact on beta-lactam clearance
Lacosamide dosing in patients receiving continuous renal replacement therapy
Adsorption and caspofungin dosing during continuous renal replacement therapy
International survey of antibiotic dosing and monitoring in adult intensive care units
Precision net ultrafiltration dosing in continuous kidney replacement therapy: a practical approach
![Neue semisynthetische β-Lactam-Antibiotika [Beta-Lactam-Antibiotika] aus Arylpyrrolidoncarbonsäuren](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Neue semisynthetische β-Lactam-Antibiotika [Beta-Lactam-Antibiotika] aus Arylpyrrolidoncarbonsäuren
Recommended β-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy
Model-informed precision dosing of beta-lactam antibiotics and ciprofloxacin in critically ill patients: a multicentre randomised clinical trial
Beta-lactam antibiotic dosing during continuous renal replacement therapy: how can we optimize therapy?
Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy
Optimization of beta-lactam dosing through targeted therapeutic drug monitoring
β-lactam antibiotic concentrations during continuous renal replacement therapy
Renal replacement therapy does have impact on beta-lactam clearance
Lacosamide dosing in patients receiving continuous renal replacement therapy
Adsorption and caspofungin dosing during continuous renal replacement therapy
International survey of antibiotic dosing and monitoring in adult intensive care units
Precision net ultrafiltration dosing in continuous kidney replacement therapy: a practical approach
Neue semisynthetische β-Lactam-Antibiotika [Beta-Lactam-Antibiotika] aus Arylpyrrolidoncarbonsäuren
Recommended β-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy
Model-informed precision dosing of beta-lactam antibiotics and ciprofloxacin in critically ill patients: a multicentre randomised clinical trial
Beta-lactam antibiotic dosing during continuous renal replacement therapy: how can we optimize therapy?
Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy
Optimization of beta-lactam dosing through targeted therapeutic drug monitoring
β-lactam antibiotic concentrations during continuous renal replacement therapy
Renal replacement therapy does have impact on beta-lactam clearance
Lacosamide dosing in patients receiving continuous renal replacement therapy
Adsorption and caspofungin dosing during continuous renal replacement therapy
International survey of antibiotic dosing and monitoring in adult intensive care units
Precision net ultrafiltration dosing in continuous kidney replacement therapy: a practical approach
Neue semisynthetische β-Lactam-Antibiotika [Beta-Lactam-Antibiotika] aus Arylpyrrolidoncarbonsäuren
Recommended β-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy